Exicure (XCUR) Revenue (2016 - 2024)
Exicure's (XCUR) quarterly Revenue came in at $500000.0 in Q1 2024, down 97.7% quarter-over-quarter from $21.8 million in Q4 2022.
Analysis
Exicure (XCUR) Revenue (2016 - 2024) Analysis & Trends
Exicure (XCUR) has reported Revenue for 8 consecutive years, with $500000.0 the latest figure, recorded in Q1 2024.
- For the quarter ending Q1 2024, Revenue changed N/A year-over-year to $500000.0; the trailing twelve-month figure through Dec 2024 stood at $500000.0 (changed N/A YoY), and the FY2024 full-year result was $500000.0, changed N/A from the prior year.
- Revenue eased to $500000.0 in Q1 2024 per XCUR's latest filing, from $21.8 million in the prior quarter.
- Across five years, Revenue topped out at $21.8 million in Q4 2022 and bottomed at -$2.1 million in Q4 2021.
- Historically, Revenue has averaged $3.7 million across 4 years, with a median of $2.4 million in 2020.
- The sharpest annual moves came in 2020 and 2021: Revenue surged 36632.0% in 2020, then slumped 1612.86% in 2021.
- Over 4 years, Revenue stood at $140000.0 in 2020, then plunged by 1612.86% to -$2.1 million in 2021, then jumped by 1128.05% to $21.8 million in 2022, then tumbled by 97.7% to $500000.0 in 2024.
- According to Business Quant data, Revenue over the past three periods registered $500000.0, $21.8 million, and $2.0 million for Q1 2024, Q4 2022, and Q3 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Exicure | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2022 | 21.77 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 2.47 Mn |
| Mar 31, 2022 | 2.57 Mn |
| Dec 31, 2021 | -2.12 Mn |
| Sep 30, 2021 | 3.68 Mn |
| Jun 30, 2021 | 79,000.00 |
| Mar 31, 2021 | 997,000.00 |
| Dec 31, 2020 | 140,000.00 |
| Sep 30, 2020 | 2.44 Mn |
| Jun 30, 2020 | 4.85 Mn |
| Mar 31, 2020 | 9.18 Mn |
| Dec 31, 2019 | 310,000.00 |
| Sep 30, 2019 | 527,000.00 |
| Jun 30, 2019 | 434,000.00 |
| Mar 31, 2019 | 25,000.00 |
| Dec 31, 2018 | 6,000.00 |
| Sep 30, 2018 | 57,000.00 |
| Jun 30, 2018 | 19,000.00 |